Spectroscopy in Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Exploiting Pathogenic Tp53 Mutation for Early Diagnosis of Ovarian Cancer by Mean of Papanicolau Test
- Status
- UNKNOWN
- Phase
- N/A
Phase 1 Dose Escalation of ArtemiCoffee
- Status
- COMPLETED
- Phase
- PHASE1
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
- Status
- COMPLETED
- Phase
- PHASE1
Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Prehabilitation in Gynaecological Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE3
A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Real-life Use of Niraparib in a Patient Access Program in Norway
- Status
- COMPLETED
- Phase
- N/A
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Evaluation of the Predictive Value of Blood Levels of Angiopoietin 1 and Endothelial Internal Tunica Cell Kinase 2 in Patients With Ovarian Cancer Treated With Chemotherapy Associated to Bevacizumab
- Status
- UNKNOWN
- Phase
- N/A
The Culture of Ovarian Cancer Organoids and Drug Screening
- Status
- UNKNOWN
- Phase
- N/A
Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer
- Status
- UNKNOWN
- Phase
- N/A
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer
- Status
- UNKNOWN
- Phase
- NA
Olaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment
- Status
- COMPLETED
- Phase
- PHASE1
A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2